In this week’s edition of InnovationRx, we look at health insurers' vows to improve prior authorization, Bell Labs’ IP ...

CRSP edges ahead of NTLA with the only approved CRISPR therapy, stronger pipeline breadth and recent stock gains.

Sales of the ground-breaking cystic fibrosis (CF) drug Kaftrio was the main driver behind revenues of a Dublin unit of Vertex ...

A stem cell-based treatment may have cured 10 out of 12 patients with the most severe form of type 1 diabetes — during a ...

Patients with occipital headache experienced relief with 60 days of peripheral nerve stimulation, according to data presented at the American Headache Society 67th Annual Scientific Meeting.“Whenever ...

Diabetes affects many people in the world, type 1 diabetes being a condition that can affect anyone, causing them to be on ...

Analysts remain bullish on Vertex Pharmaceuticals as HC Wainwright reaffirmed its buy rating with a $550 price target.

Google (NASDAQ:GOOGL) has launched Gemini CLI, a free and open-source AI agent that integrates directly into developers’ ...

The American Diabetes Association's McCormick Place event was also a bit of a coming out party for North Chicago-based Abbott's new head of diabetes business.

The BAFF- and APRIL-targeted therapies market is experiencing steady growth driven by the rising prevalence of autoimmune diseases such as sy ...

Just hours after President Donald Trump announced a ceasefire between Israel and Iran effective at midnight, that deal seemed shaky as further strikes loomed in the region before a fiery Trump lashed ...